Literature DB >> 12150895

Positive selection of a Qa-1-restricted T cell receptor with specificity for insulin.

Barbara A Sullivan1, Piotr Kraj, Dominique A Weber, Leszek Ignatowicz, Peter E Jensen.   

Abstract

The phenotype and development of T cells from transgenic mice expressing a T cell receptor with specificity for insulin presented by the MHC class Ib molecule Qa-1(b) was investigated. Peripheral T cells from the transgenic mice express CD8 and, after activation, kill Qa-1(b)-positive lymphoid target cells in the presence of soluble insulin. Thymic selection requires expression of Qa-1(b) but not the dominant Qa-1-associated peptide, Qdm. In contrast to conventional T cells, selection is at least as efficient when the selecting ligand is expressed only on hematopoietic lineage cells as compared to expression on epithelial cells in the thymus. Our findings suggest that there is a dedicated population of Qa-1-restricted T cells that are selected by interaction with Qa-1 and that the cellular requirements for selection may differ from conventional T cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12150895     DOI: 10.1016/s1074-7613(02)00343-6

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  17 in total

Review 1.  Regulation of self-tolerance by Qa-1-restricted CD8(+) regulatory T cells.

Authors:  Hye-Jung Kim; Harvey Cantor
Journal:  Semin Immunol       Date:  2011-12       Impact factor: 11.130

Review 2.  Qa-1 restriction of CD8+ suppressor T cells.

Authors:  Stefanie Sarantopoulos; Linrong Lu; Harvey Cantor
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

3.  Regulation of activated CD4+ T cells by NK cells via the Qa-1-NKG2A inhibitory pathway.

Authors:  Linrong Lu; Koichi Ikizawa; Dan Hu; Miriam B F Werneck; Kai W Wucherpfennig; Harvey Cantor
Journal:  Immunity       Date:  2007-05       Impact factor: 31.745

4.  Expression of the mouse MHC class Ib H2-T11 gene product, a paralog of H2-T23 (Qa-1) with shared peptide-binding specificity.

Authors:  Lili Chen; Eduardo Reyes-Vargas; Hu Dai; Hernando Escobar; Brant Rudd; Jared Fairbanks; Alexander Ho; Mathew F Cusick; Attila Kumánovics; Julio Delgado; Xiao He; Peter E Jensen
Journal:  J Immunol       Date:  2014-06-23       Impact factor: 5.422

5.  Positive selecting cell type determines the phenotype of MHC class Ib-restricted CD8+ T cells.

Authors:  Hoonsik Cho; Yaw Bediako; Honglin Xu; Hak-Jong Choi; Chyung-Ru Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-25       Impact factor: 11.205

6.  TGF-β prevents T follicular helper cell accumulation and B cell autoreactivity.

Authors:  Mark J McCarron; Julien C Marie
Journal:  J Clin Invest       Date:  2014-08-26       Impact factor: 14.808

7.  Suppression of autoimmune disease after vaccination with autoreactive T cells that express Qa-1 peptide complexes.

Authors:  Vily Panoutsakopoulou; Katharina M Huster; Nami McCarty; Evan Feinberg; Rijian Wang; Kai W Wucherpfennig; Harvey Cantor
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

8.  Mycobacterium tuberculosis peptides presented by HLA-E molecules are targets for human CD8 T-cells with cytotoxic as well as regulatory activity.

Authors:  Simone A Joosten; Krista E van Meijgaarden; Pascale C van Weeren; Fatima Kazi; Annemieke Geluk; Nigel D L Savage; Jan W Drijfhout; Darren R Flower; Willem A Hanekom; Michèl R Klein; Tom H M Ottenhoff
Journal:  PLoS Pathog       Date:  2010-02-26       Impact factor: 6.823

Review 9.  The role of MHC class Ib-restricted T cells during infection.

Authors:  Courtney K Anderson; Laurent Brossay
Journal:  Immunogenetics       Date:  2016-07-01       Impact factor: 2.846

10.  The nonpolymorphic MHC Qa-1b mediates CD8+ T cell surveillance of antigen-processing defects.

Authors:  Cláudia C Oliveira; Peter A van Veelen; Bianca Querido; Arnoud de Ru; Marjolein Sluijter; Sandra Laban; Jan W Drijfhout; Sjoerd H van der Burg; Rienk Offringa; Thorbald van Hall
Journal:  J Exp Med       Date:  2009-12-28       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.